Navigation Links
First Ever Patch Drug To Treat Parkinsons Symptoms Approved

The U.S. Food and Drug administration on Wednesday approved a new patch-drug, the first ever medicine to treat the symptoms of Parkinson's disease . Known by the name Neupro, the once-daily patch is manufactured by Schwarz Pharma AG. The patch contains a drug called rotigotine, which has not been sold before in the United States.

Parkinsons disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement.

In a healthy brain, certain brain cells produce a chemical called dopamine, which helps the brain coordinate the body's movements while in the patients who suffer from Parkinson's, dopamine-producing brain cells cannot survive. Dopamine is crucial for the communication between cells that control muscle movement hence the sufferers of PD are often seen trembling.

Accordingly, the rotigotine present in the Neupro patch works by activating dopamine receptors in the brain, imitating the neurotransmitter's effect. The FDA determined the effectiveness of Neupro's by three studies that included 1,154 patients with early Parkinson's disease who were not taking other Parkinson's medications.

Rotigotine is a member of a class of drugs called dopamine agonists, which mimic dopamine's effects.

Other Parkinson's disease drugs are given orally. Those drugs are effective, but some patients experience a wearing-off effect at the end of each dose. The Parkinson's patch is designed to solve that problem.

However, the patch also has some side effects that include skin reactions at the patch site, dizziness, nausea, vomiting, drowsiness and insomnia. Also, the patient using this patch can experience a sudden onset of sleep while doing some activities like driving or operating machinery. Other side effects also include hallucinat ions and decreased blood pressure when standing up.

An estimated 1 million people in the U.S. have Parkinson's, with an additional 60,000 cases diagnosed each year.


'"/>




Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... , ... February 05, 2016 , ... Stuart Bentkover, ... technology, the PicoSure. Designed to provide the most effective tattoo removal today, Dr. Bentkover ... unmatched results. , Developed by Cynosure, the PicoSure has been approved by the Food ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of ... A hallmark feature of patients with eating disorders is significant self-criticism, and consequently these ... and obsessions are regarded as maladaptive means for coping with this unease, but also ...
(Date:2/5/2016)... ... February 05, 2016 , ... On June ... Diseases, a continuing medical education (CME) event presented by the Association for Comprehensive ... a first for ACCORD, whose mission is to provide education, tools, and resources ...
(Date:2/5/2016)... Atascadero, CA (PRWEB) , ... February 05, 2016 , ... ... report on the benefits of having a tankless water heater. To view the report, ... of water heaters: tank and tankless. While each has their pros and cons, the ...
(Date:2/4/2016)... Verdes, CA (PRWEB) , ... February 04, 2016 ... ... at the "It's All About YOU Re-Treat" on February 19-21, 2016, in ... Re-Treat" is at Rancho Palos Verdes, California. These 30 professional speakers, including Clinical ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)...  AMRI (NASDAQ:  AMRI) today announced that Anthony J. ... of Pfizer Global Supply, has been elected to the AMRI ... addition, the Company announced that Mr. Gabe Leung , ... has retired from the AMRI Board of Directors in order ... ventures.  William S. Marth , President and ...
(Date:2/4/2016)... India , February 4, 2016 ... the new Market Research Report "North American Automated External ... Fully-Automated External Defibrillators), by End-User (Public Facilities, Hospitals, Homecare ... American automated external defibrillators (AED) report defines and segments ... the revenue. This market is estimated to grow to ...
(Date:2/4/2016)... India , February 4, 2016 ... market research report "Digital X-ray Market by Application (Mammography, Dental, ... Type of System, End User (Diagnostic Center, Hospitals), Price - ... is expected to reach USD 10.46 Billion by 2020 from ... from 2015 to 2020. Brow se 270 ...
Breaking Medicine Technology: